Skip to Content
Merck

Involvement of leukotriene B4 in dermatophyte-related itch in mice.

Pharmacological reports : PR (2014-06-21)
Tsugunobu Andoh, Yusuke Takayama, Yasushi Kuraishi
ABSTRACT

Proteinase-activated receptor-2 (PAR2) is involved in dermatophyte-induced scratching and leukotriene B4 (LTB4) release from keratinocytes. We investigated whether PAR2-mediated LTB4 production is involved in dermatophyte-induced scratching. Dermatophyte extract was injected intradermally and scratching was observed in mice. LTB4 was determined by enzyme immunoassay. Dermatophyte extract-induced scratching was inhibited by zileuton (5-lipoxygenase inhibitor), ONO-4057 (LTB4 antagonist), FSLLRY-NH2 (PAR2 antagonist), and anti-PAR2 antibody. Dermatophyte extract injection increased the cutaneous content of LTB4, which was inhibited by zileuton and FSLLRY-NH2. These results suggest the involvement of LTB4 in dermatophyte-associated itch. LTB4 production might be due to PAR2 stimulation in the skin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Valeric acid, ≥99%
Sigma-Aldrich
Valeric acid, ≥99%, FCC, FG
Supelco
Valeric acid, analytical standard